Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05178784 · ClinicalTrials.gov registry record
EEG Biomarker Study for Participants in the Neurolief "MOOD" Trial
A clinical trial of Depression, sponsored by Butler Hospital.
- Active
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT05178784 is a study of Depression that is active but no longer recruiting, run by Butler Hospital. The registered enrollment target is 40 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05178784, a study of Depression, is active but no longer recruiting, sponsored by Butler Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will collect EEG data at 3 time points from up to 40 adults who are enrolled in a double clinical trial investigating a device that delivers noninvasive, self-administered external Combined Occipital and Trigeminal Neurostimulation (eCOT-NS) treatment for Major Depressive Disorder (Relivion®DP). Baseline (Pre-treatment) Frontal EEG Alpha Oscillations (Power) will be compared post-stimulation power.
Conditions Studied
Interventions
- DEVICE External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) stimulation
Study Locations (1)
Rhode Island
- Butler Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-11-16 |
| Est. Completion | 2025-11-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05178784
The ClinicalTrials.gov registry entry for NCT05178784 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) stimulation is the first listed.
NCT05178784 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05178784 about?
NCT05178784 is a clinical study titled "EEG Biomarker Study for Participants in the Neurolief "MOOD" Trial". This study will collect EEG data at 3 time points from up to 40 adults who are enrolled in a double clinical trial investigating a device that delivers noninvasive, self-administered external Combined Occipital and Trigeminal Neurostimulation (eCOT-NS) treatment for Major Depressive Disorder (Relivi...
What is the current status of trial NCT05178784?
This trial is currently active not recruiting. The enrollment target is 40 participants. The study started on 2021-11-16. Estimated completion is 2025-11-16.
What conditions does trial NCT05178784 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT05178784?
The interventions under investigation include: External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) stimulation (DEVICE).
Who is sponsoring clinical trial NCT05178784?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05178784 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.